Regulated information
Waregem (Belgium)/Rotterdam (Netherlands)[1], 21 September 2015
Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received a joint notification on 17 September 2015 from Alychlo NV and Marc Coucke concerning the acquisition of voting securities. The joint shareholding of Alychlo NV and Marc Coucke crossed the disclosure threshold of 5% through the acquisition of voting securities. Alychlo NV is controlled by Marc Coucke.
Based on the denominator of 32,111,827 (total number of voting rights) and the latest received notifications, the major shareholders of Fagron are:
Number of shares % of effective voting rights Carmignac Gestion 2,463,267 7.67% Alychlo NV / Marc Coucke 1,709,601 5.32% TIAA-CREF Asset Management LLC 1,635,681 5.09% BNP Paribas Investment Partners SA 1,554,073 4.84% Fidelity Management and Research (FMR LLC) 1,517,822 4.73% Consonance Capital Management[2] > 3% Danske Bank 930,086 2.90%The original notification forms are available on the website investors.fagron.com.
For further information
Jan Peeters
Chief Financial Officer
Tel. +31 88 331 12 52
jan.peeters@fagron.com
Fagron profile
Fagron is a scientific pharmaceutical R&D company that is focused on optimizing and innovating customized pharmaceutical care. Fagron provides Fagron Specialty Pharma Services, Fagron Trademarks and Fagron Essentials to pharmacies, clinics and hospitals in 32 countries worldwide.
The Belgian company Fagron NV is located in Waregem and is listed on Euronext Brussels and Euronext Amsterdam. The operational activities of Fagron are driven by the Dutch company Fagron BV. The head office of Fagron BV is located in Rotterdam.
[1] This press release was sent out by Fagron NV and Fagron BV.
[2] On 18 September 2015, Consonance Capital Management informed Fagron that they have a shareholding in Fagron of 1,340,391 shares or 4.17% of the total number of voting rights. Fagron already received a notification on 31 July 2015 that the shareholding of Consonance Capital Management crossed the disclosure threshold of 3% through the acquisition of voting securities. Fagron disclosed this notification in a press release that was published on 4 August 2015.
Please open the link below for the press release: